首页> 外文期刊>Journal of the American College of Surgeons >Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys
【24h】

Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys

机译:使用腹腔镜获取多条肾动脉肾脏和右肾进行活体供体肾脏移植

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The use of kidneys with multiple renal arteries (MRA) and right kidneys procured laparoscopically for living donor kidney transplantation (LDKT) remains controversial. We aimed to evaluate the short- and long-term outcomes of recipients of LDKT using laparoscopically procured MRA and right kidneys. Study Design: We reviewed the medical records of all LDKT recipients with laparoscopically procured kidneys from 2000 to 2009. Pediatric recipients and recipients of positive crossmatch and/or ABO-incompatible transplants were excluded. We compared the outcomes of recipients of MRA kidneys with those receiving single renal artery (SRA) kidneys and the outcomes of recipients of right kidneys with those of left kidneys. Renal function was measured by iothalamate clearance and estimated by the abbreviated Modification of Diet in Renal Disease equation. Results: Multiple renal artery kidneys (192 2-artery and 18 3-artery kidneys) were used in 210 (18.5%) of 1,134 transplantations. The most common reconstructive technique used for MRA kidneys was a side-to-side anastomosis (64.3%). There were no significant differences in vascular complications (1.1% vs 2.4%, p = 0.17), urologic complications (3.1% vs 2.9%, p = 0.47), graft survival at 1 year (94.6% vs 96.1%, p = 0.37), and 1-year iothalamate clearance (64 mL/min/1.73 m2 vs 66 mL/min/1.73 m 2, p = 0.52) between recipients of SRA and MRA kidneys. Five-year graft survival was similar for recipients of SRA and MRA kidneys (83.6% vs 82.6%, p = 0.82) and for recipients of left vs right kidneys (83.7% vs 82.6%, p = 0.70). Conclusions: Excellent long-term outcomes can be obtained after LDKT using laparoscopically procured MRA and right-sided donor kidneys. Unavailability of an SRA left kidney should not preclude LDKT.
机译:背景:使用带多条肾动脉的肾脏和腹腔镜采购的右肾进行活体供体肾脏移植(LDKT)仍存在争议。我们的目标是使用腹腔镜下MRA和右肾评估LDKT接受者的短期和长期结局。研究设计:我们回顾了从2000年到2009年所有LDKT接受腹腔镜手术肾脏治疗的接受者的病历。小儿接受者和交叉匹配和/或ABO不相容移植阳性的接受者被排除在外。我们比较了接受MRA肾脏接受者和接受单肾动脉(SRA)肾者的结局,比较了右肾接受者与左肾接受者的结局。肾功能通过碘乙酸酯清除率测量,并通过在肾脏疾病方程式中饮食的缩写修改来估计。结果:在1,134例移植物中,有210例(18.5%)使用了多个肾动脉肾脏(192个2动脉和18个3动脉肾脏)。用于MRA肾脏的最常见的重建技术是侧向吻合(64.3%)。血管并发症(1.1%vs 2.4%,p = 0.17),泌尿科并发症(3.1%vs 2.9%,p = 0.47),1年移植物存活率(94.6%vs 96.1%,p = 0.37)无显着差异。 ,SRA和MRA肾脏接受者之间的1年碘乙酸酯清除率(64 mL / min / 1.73 m2与66 mL / min / 1.73 m 2,p = 0.52)。 SRA和MRA肾脏的接受者的五年移植物存活率相似(分别为83.6%和82.6%,p = 0.82)和左,右肾脏接受者(83.7%和82.6%,p = 0.70)。结论:使用腹腔镜采购的MRA和右侧供体肾脏在LDKT后可获得良好的长期预后。无法使用SRA左肾不应排除LDKT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号